Last reviewed · How we verify

NCT06639763: AID

Erectile Aid Use in Post-phalloplasty and Post-metoidioplasty Transgender Patients

Recruiting now Last updated 15 October 2024
What this trial tests

trial testing Questionnaire in Transgenderism in 1,000 participants. Currently enrolling.

Timeline
6 July 2024
Primary endpoint
30 June 2025
30 June 2025

Quick facts

Lead sponsorUniversity Hospital, Ghent
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment1,000
Start date6 July 2024
Primary completion30 June 2025
Estimated completion30 June 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Ghent

Who can join

18 and older, female only, with Transgenderism or Erectile Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to explore the various methods used by transgender men for sexual intercourse following phalloplasty or metoidioplasty, focusing on their satisfaction with different erectile aids, as well as the satisfaction of their partners. Phalloplasty and metoidioplasty are gender-affirming surgeries that often require additional aids to achieve the desired sexual function, particularly for penetration. While internal erectile prostheses are common after phalloplasty, they come with high complication rates, leading some patients to opt for non-surgical aids. However, the effectiveness and comfort of these aids are not well-documented. This study aims to fill this gap by examining the types of aids transgender men use, how well these aids meet their sexual needs, and how satisfied both they and their partners are with the outcomes, providing much-needed insight for healthcare providers and patients alike.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Transgenderism

Currently open trials in the same condition.

Other University Hospital, Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06639763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing